{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:42:15Z","timestamp":1771008135187,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ZW7-85152953"],"award-info":[{"award-number":["ZW7-85152953"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"F\u00f6rderschwerpunktprogramm des COVID-19 Forschungsnetzwerks Niedersachsen","award":["8FT21"],"award-info":[{"award-number":["8FT21"]}]},{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Immunocompromised people (ICP) and elderly individuals (older than 80\u00a0years) are at increased risk for severe coronavirus infections. To protect against serious infection with SARS-CoV-2, ICP are taking precautions that may include a reduction of social contacts and participation in activities which they normally enjoy. Furthermore, for these people, there is an uncertainty regarding the effectiveness of the vaccination. The COVID-19 Contact (CoCo) Immune study strives to characterize the immune response to COVID-19 vaccination in immunocompromised, elderly people, and patients with hematological or oncological diseases. The study uses blood-based screenings to monitor the humoral and cellular immune response in these groups after vaccination. Questionnaires and qualitative interviews are used to describe the level of social participation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The CoCo Immune Study is a mixed methods prospective, longitudinal, observational study at two large university hospitals in Northern Germany. Starting in March 2021, it monitors anti-SARS-CoV-2 immune responses and collects information on social participation in more than 600 participants, at least 18\u00a0years old. Inclusion criteria and subcohorts: Participants with (1) regularly intake of immunosuppressive medication (ICP-cohort) or (2) age\u2009\u2265\u200980\u00a0years (80\u2009+\u2009-cohort). Additionally, patients with current or former (3) myeloid, (4) lymphatic disease or (5) solid tumor under checkpoint inhibition (3\u20135: HO-cohort). Exclusion criteria: (1) refusal to give informed consent, (2) contraindication to blood testing, (3) inability to declare consent. Participants complete a questionnaire at four different time points: prior to full vaccination, and 1, 6 and 12\u00a0months after completed vaccination. In addition, participants draw blood samples themselves or through a local health care provider and send them with their questionnaires per post at the respective time points after vaccination. Patients of the HO cohort dispense additional blood samples at week 3 to 12 and at month 6 to 9 after 2nd vaccination to gain additional knowledge in B and T cell responses. Selected participants are invited to qualitative interviews about social participation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This observational study is designed to gain insight into the immune response of people with weakened immune systems and to find out how social participation is affected after COVID-19 vaccination.<\/jats:p>\n                <jats:p><jats:italic>Trial registration:<\/jats:italic> This study was registered with German Clinical Trial Registry (registration number: DRKS00023972) on 30th December 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07347-w","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T10:04:24Z","timestamp":1650881064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study"],"prefix":"10.1186","volume":"22","author":[{"given":"Alexandra","family":"Dopfer-Jablonka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Mikuteit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Niewolik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Cossmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metodi V.","family":"Stankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg M. N.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Hummers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Heesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3564-4725","authenticated-orcid":false,"given":"Dominik","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Roder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Klawonn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Vahldiek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Hasenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Kallusky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine S.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias R.","family":"Overbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"7347_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(20)30185-9.","journal-title":"Lancet"},{"key":"7347_CR2","unstructured":"Robert Koch-Institut. Coronavirus SARS-CoV-2 - COVID-19 [Coronavirus SARS-CoV-2 - COVID-19]: Fallzahlen in Deutschland und weltweit [Case numbers in Germany and worldwide]. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Fallzahlen.html. Accessed on 20 October 2021."},{"key":"7347_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, Barnaby DP, Becker LB, Chelico JD, Cohen SL, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052\u20139. https:\/\/doi.org\/10.1001\/jama.2020.6775.","journal-title":"JAMA"},{"key":"7347_CR4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626\u201331. https:\/\/doi.org\/10.1038\/s41591-021-01292-y.","journal-title":"Nat Med"},{"key":"7347_CR5","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1111\/ajt.15967","volume":"20","author":"V Nair","year":"2020","unstructured":"Nair V, Jandovitz N, Hirsch JS, Nair G, Abate M, Bhaskaran M, Grodstein E, Berlinrut I, Hirschwerk D, Cohen SL, et al. COVID-19 in kidney transplant recipients. Am J Transplant. 2020;20:1819\u201325. https:\/\/doi.org\/10.1111\/ajt.15967.","journal-title":"Am J Transplant"},{"key":"7347_CR6","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMc2011117","volume":"382","author":"E Akalin","year":"2020","unstructured":"Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, Ross M, Forest S, Goldstein YD, Ajaimy M, et al. COVID-19 and kidney transplantation. N Engl J Med. 2020;382:2475\u20137. https:\/\/doi.org\/10.1056\/NEJMc2011117.","journal-title":"N Engl J Med"},{"key":"7347_CR7","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/ajt.15941","volume":"20","author":"MR Pereira","year":"2020","unstructured":"Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, Arcasoy S, Aversa MM, Benvenuto LJ, Dadhania DM, et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020;20:1800\u20138. https:\/\/doi.org\/10.1111\/ajt.15941.","journal-title":"Am J Transplant"},{"key":"7347_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2468-1253(20)30125-4","volume":"5","author":"GJ Webb","year":"2020","unstructured":"Webb GJ, Moon AM, Barnes E, Barritt AS, Marjot T. Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastroenterol Hepatol. 2020;5:643\u20134. https:\/\/doi.org\/10.1016\/S2468-1253(20)30125-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7347_CR9","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","volume":"34","author":"W He","year":"2020","unstructured":"He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34:1637\u201345. https:\/\/doi.org\/10.1038\/s41375-020-0836-7.","journal-title":"Leukemia"},{"key":"7347_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79:859\u201366. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871.","journal-title":"Ann Rheum Dis"},{"key":"7347_CR11","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.41.2100920","author":"T Harder","year":"2021","unstructured":"Harder T, K\u00fclper-Schiek W, Reda S, Treskova-Schwarzbach M, Koch J, Vygen-Bonnet S, Wichmann O. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021. Euro Surveill. 2021. https:\/\/doi.org\/10.2807\/1560-7917.ES.2021.26.41.2100920.","journal-title":"Euro Surveill."},{"key":"7347_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10067-020-05547-w","volume":"40","author":"B Sonani","year":"2021","unstructured":"Sonani B, Aslam F, Goyal A, Patel J, Bansal P. COVID-19 vaccination in immunocompromised patients. Clin Rheumatol. 2021;40:797\u20138. https:\/\/doi.org\/10.1007\/s10067-020-05547-w.","journal-title":"Clin Rheumatol"},{"key":"7347_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3899\/jrheum.170710","volume":"45","author":"S Subesinghe","year":"2018","unstructured":"Subesinghe S, Bechman K, Rutherford AI, Goldblatt D, Galloway JB. A systematic review and metaanalysis of antirheumatic drugs and vaccine immunogenicity in rheumatoid arthritis. J Rheumatol. 2018;45:733\u201344. https:\/\/doi.org\/10.3899\/jrheum.170710.","journal-title":"J Rheumatol"},{"key":"7347_CR14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/acr.22246","volume":"66","author":"C Hua","year":"2014","unstructured":"Hua C, Barnetche T, Combe B, Morel J. Effect of methotrexate, anti-tumor necrosis factor \u03b1, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2014;66:1016\u201326. https:\/\/doi.org\/10.1002\/acr.22246.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7347_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/annrheumdis-2018-214025","volume":"78","author":"JK Park","year":"2019","unstructured":"Park JK, Lee YJ, Bitoun S, Winthrop KL, Choi Y, Lee EB, Mariette X. Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis. 2019;78:282\u20134. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214025.","journal-title":"Ann Rheum Dis"},{"key":"7347_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.11.21256917","author":"RH Haberman","year":"2021","unstructured":"Haberman RH, Herati RS, Simon D, Samanovic M, Blank RB, Tuen M, Koralov SB, Atreya R, Tascilar K, Allen JR, et al. Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. medRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.05.11.21256917.","journal-title":"medRxiv"},{"key":"7347_CR17","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2665-9913(21)00212-5","volume":"3","author":"SK Mahil","year":"2021","unstructured":"Mahil SK, Bechman K, Raharja A, Domingo-Vila C, Baudry D, Brown MA, Cope AP, Dasandi T, Graham C, Lechmere T, et al. The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study. Lancet Rheumatol. 2021;3:e627\u201337. https:\/\/doi.org\/10.1016\/S2665-9913(21)00212-5.","journal-title":"Lancet Rheumatol"},{"key":"7347_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab153","author":"N Chanchlani","year":"2021","unstructured":"Chanchlani N, Lin S, Chee D, Hamilton B, Nice R, Zehra A, Bewshea C, Cipriano B, Derikx LAAP, Dunlop A, et al. Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients. J Crohns Colitis. 2021. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab153.","journal-title":"J Crohns Colitis"},{"key":"7347_CR19","doi-asserted-by":"publisher","unstructured":"Jablonka A, Happle C, Cossmann A, Stankov MV, Scharff AZ, Ernst D, Behrens GM. Protocol for longitudinal assessment of SARS-CoV-2-specific immune responses in healthcare professionals in Hannover, Germany: the prospective, longitudinal, observational COVID-19 Contact (CoCo) study. 2020. doi:https:\/\/doi.org\/10.1101\/2020.12.02.20242479.","DOI":"10.1101\/2020.12.02.20242479"},{"key":"7347_CR20","unstructured":"Deck R, Mittag O, H\u00fcppe A, Muche-Borowski C, Raspe H. IMET - Index for the Measurement of Participation Limitations [IMET - Index zur Messung von Einschr\u00e4nkungen der Teilhabe], 2011."},{"key":"7347_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","volume":"122","author":"B L\u00f6we","year":"2010","unstructured":"L\u00f6we B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Br\u00e4hler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122:86\u201395. https:\/\/doi.org\/10.1016\/j.jad.2009.06.019.","journal-title":"J Affect Disord"},{"key":"7347_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","volume":"146","author":"K Kroenke","year":"2007","unstructured":"Kroenke K, Spitzer RL, Williams JBW, Monahan PO, L\u00f6we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317\u201325. https:\/\/doi.org\/10.7326\/0003-4819-146-5-200703060-00004.","journal-title":"Ann Intern Med"},{"key":"7347_CR23","unstructured":"Horstk\u00f6tter N, M\u00fcller U, Ommen O, Reckendrees B, Stander V, Lang P, Thaiss H. Attitudes, knowledge, and behaviors of adults and parents toward vaccinations [Einstellungen, Wissen und Verhalten von Erwachsenen und Eltern gegen\u00fcber Impfungen]: Ergebnisse der Repr\u00e4sentativbefragung 2018 zum Infektionsschutz. BZgA-Forschungsbericht., K\u00f6ln, 2019."},{"key":"7347_CR24","unstructured":"Kuckartz, U. Qualitative content analysis. Methods, practice, computer support [Qualitative Inhaltsanalyse. Methoden, Praxis, Computerunterst\u00fctzung], 3. \u00fcberarbeitete Auflage; Juventa: Weinheim, Basel, 2016, ISBN 9783779943860 3779943867."},{"key":"7347_CR25","unstructured":"Dresing T, Pehl T. Praxisbuch Interview, Transkription & Analyse [Interview, Transcription & Analysis Practice Book]: Guidance and control systems for qualitative researchers [Anleitungen und Regelsysteme f\u00fcr qualitativ Forschende], 6. Auflage; Marburg, 2015, ISBN ISBN 978-3-8185-0489-2."},{"key":"7347_CR26","unstructured":"Mayring, P. Qualitative content analysis, basics and techniques [Qualitative Inhaltsanalyse, Grundlagen und Techniken], 12., aktualisierte und \u00fcberarb. Aufl.; Beltz, 2015, ISBN 3-407-29142-6."},{"key":"7347_CR27","unstructured":"Digital Curation Centre. Checklist for a Data Management Plan. Available online: https:\/\/www.dcc.ac.uk\/sites\/default\/files\/documents\/resource\/DMP\/DMP_Checklist_2013.pdf."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07347-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07347-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07347-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T10:05:32Z","timestamp":1650881132000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07347-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7347"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07347-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"20 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics vote was obtained from the Ethics Committee of the University Medical Center G\u00f6ttingen (No. 29\/3\/21). The study is registered in the German Clinical Trials Register, an approved Primary Register in the WHO network (DRKS00023972). Informed consent is\/was obtained written from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"403"}}